Jindan Yu

13PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursReaction engineering (excl. nuclear reactions)Deep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2026
FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment.

Lourdes Brea, Hongshun Shi, Viriya Keo

|Jan 07, 2026
EZH2 PROTACs outperform catalytic inhibitors in prostate cancer by targeting a methylation-independent function of PRC2.

Wanqing Xie, Qi Chu, Lourdes Brea

|Jul 21, 2025
NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling.

Xiaodong Lu, Viriya Keo, Irina Cheng

|Dec 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target.

Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang

|Jun 19, 2023
Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target.

Marina Ferrari, Li Wang, Luke Hoeppner

|May 17, 2023
Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer.

Zhuoyuan Lin, Shivani Agarwal, Song Tan

Pageof 3

Frequent Collaborators

7 joint publications

Xiaodong Lu

5 joint publications

Lourdes T Brea

5 joint publications

Jonathan C Zhao

4 joint publications

Galina Gritsina